Navigation Links
Bio-Optronics Adds Innovative Electronic Data Capture (EDC) Solution to Clinical Conductor Clinical Trial Management System (CTMS), Continues to Improve Workflow and Productivity
Date:4/14/2009

ROCHESTER, N.Y., April 14 /PRNewswire/ -- Bio-Optronics, Inc. and flexcipio s.a. are pleased to announce an agreement to cross-market and integrate Bio-Optronics' Clinical Conductor Clinical Trial Management System (CTMS) and flexcipio's eClinical Electronic Data Capture (EDC) solution. This aligns the industry's most comprehensive enterprise CTMS, with an innovative EDC, to provide clinical research with the best tools to optimize efficiency, productivity, and improve collaboration across the clinical environment. Clinical Conductor CTMS provides natural points in clinical trial workflow into which best-in-class tools and expertise can be integrated seamlessly.

Dan Kerpelman, Bio-Optronics President and CEO states, "Our extensive workflow expertise is a perfect match to flexcipio's data capture expertise." Pierre Ghyssens, flexcipio General Manager adds "Both our companies are dedicated to developing the latest solutions. By combining forces, we are able to provide a unique, global offering to the health sector."

Clinical Conductor CTMS, proven to improve site efficiency and productivity, handles the complete enterprise workflow, from business development, to patient databases, recruitment, scheduling, workload planning, finances, and complete oversight and reporting. The academic medical center CTMS solution adds research administration capabilities and custom interfaces to hospital enterprise systems.

eClinical EDC delivers powerful functionality and flexibility through a rich, interactive, user-friendly web-browser interface. EDC features include database definition, form design, QA process set-up, and powerful reporting. And, users are empowered to adapt the electronic data capture environment, intuitively. Qualified to the highest quality standards, data integrity and security are ensured, along with CDISC compliance.

Bio-Optronics, Inc. develops, deploys, and operates software products and custom information technology solutions to help healthcare professionals manage and optimize workflow, thus enhancing quality, productivity, and patient and staff satisfaction. For over 20 years, Bio-Optronics has demonstrated leadership in innovation, expertise in workflow and integration, and a singular approach to unparalleled customer service. Our workflow solutions are used in over 30 Veterans' Administration and other hospitals in the U.S., and over 400 clinical research sites around the world. www.bio-optronics.com

Flexcipio s.a., founded with a team of IT professionals and business specialists, focuses on applying the team's collective industries knowledge, experience, and professional network in a way that accelerates the design and the commercialization of innovative services, products, ideas, and technologies related to data capture. Flexcipio provides integrated web-based solutions that address industry needs for capturing and managing data in ensuring quality, security, and confidentially of collected information. www.flexcipio.com

Bio-Optronics, (877) 279-8377, www.bio-optronics.com; Maria Durkin, VP, Director Marketing and Operations, mdurkin@bio-optronics.com


'/>"/>
SOURCE Bio-Optronics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Former GE, Kodak and SGS Executive Dan Kerpelman to Join Bio-Optronics as President and CEO
2. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
3. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System
4. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
7. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
8. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug
9. Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis
10. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
11. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Research and Markets has announced the addition of the ... Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their ... Cancer ... reach $15,737 million by 2022 from $6,521 in 2015, growing at ... Omic technologies segment accounted for more than half of the revenue ...
(Date:1/19/2017)... Basel, Switzerland (PRWEB) , ... ... ... leading provider of advanced software solutions for pharmaceutical research and development (R&D), ... project-based expertise in omic data analysis and interpretation for the rapidly evolving ...
(Date:1/19/2017)... ... January 18, 2017 , ... The American Medical Informatics ... its Data Sharing Policy. Specifically, the nation’s leading informatics experts, said data sharing ... existing policy. AMIA recommended that NIH earmark funding for researchers to produce and ...
(Date:1/19/2017)... 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW ... therapies for operable and inoperable solid tumor cancers, announced ... Officer of NW Bio, will present at the Phacilitate ... the Hyatt Regency Hotel in Miami, Florida ... session entitled "New Therapeutic Approaches – Expanding the Reach ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)... Dec. 14, 2016 "Increase in mobile transactions ... The mobile biometrics market is expected to grow from ... by 2022, at a CAGR of 29.3% between 2016 ... as the growing demand for smart devices, government initiatives, ... "Software component is expected to grow at a ...
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):